Haplotype and mutation analysis of the TGFBR3 gene in Chinese women with idiopathic premature ovarian failure

Gynecological Endocrinology

Volumn 28, Issue 1, 2012, Pages 63-67

  Qin, Chun Rong ^a   Chen, Shi Ling ^a   Yao, Ji Long ^a   Li, Tao ^a   Wu, Wei Qing ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Mutation; Premature ovarian failure; TGFBR3

Indexed keywords

DNA FRAGMENT; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3;

ARTICLE; CHINESE; CONTROLLED STUDY; DNA FLANKING REGION; DNA SEQUENCE; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; IDIOPATHIC DISEASE; INTRON; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MODELS, BIOLOGICAL; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRIMARY OVARIAN INSUFFICIENCY; PROTEOGLYCANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 83655165289     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2011.583954     Document Type: Article

References (21)

1. Santoro N. Mechanisms of premature ovarian failure. Ann Endocrinol (Paris) 2003;64:87-92. (Pubitemid 36565160)
2. Timmreck LS, Reindollar RH. Contemporary issues in primary amenorrhea. Obstet Gynecol Clin North Am 2003;30:287-302.
3. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604-606. (Pubitemid 16116286)
4. Conway GS, Kaltsas G, Patel A, Davies MC, Jacobs HS. Characterization of idiopathic premature ovarian failure. Fertil Steril 1996;65:337-341. (Pubitemid 26043830)
5. Beck-Peccoz P, Persani L. Premature ovarian failure. Orphanet J Rare Dis 2006;1:9.
6. Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM, Vale W. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 2000;404:411-414. (Pubitemid 30164345)
7. López-Casillas F, Wrana JL, MassaguéJ. Betaglycan presents ligand to the TGF beta signaling receptor. Cell 1993;73:1435-1444. (Pubitemid 23201155)
8. Ethier JF, Farnworth PG, Findlay JK, Ooi GT. Transforming growth factor-beta modulates inhibin A bioactivity in the LbetaT2 gonadotrope cell line by competing for binding to betaglycan. Mol Endocrinol 2002;16:2754-2763. (Pubitemid 36020656)
9. Esparza-Lopez J, Montiel JL, Vilchis-Landeros MM, Okadome T, Miyazono K, López-Casillas F. Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factorbeta and inhibin A. J Biol Chem 2001;276:14588-14596.
10. Wiater E, Vale W. Inhibin is an antagonist of bone morphogenetic protein signaling. J Biol Chem 2003;278:7934-7941. (Pubitemid 36800530)
11. Dixit H, Deendayal M, Singh L. Mutational analysis of the mature peptide region of inhibin genes in Indian women with ovarian failure. Hum Reprod 2004;19:1760-1764. (Pubitemid 39144618)
12. Dixit H, Rao KL, Padmalatha VV, Kanakavalli M, Deenadayal M, Gupta N, Chakrabarty BN, Singh L. Mutational analysis of the betaglycan gene-coding region in susceptibility for ovarian failure. Hum Reprod 2006;21:2041-2046. (Pubitemid 44288079)
13. Prakash GJ, Kanth VV, Shelling AN, Rozati R, Sujatha M. Absence of 566C
14. Zintzaras E. Inhibin alpha gene and susceptibility to premature ovarian failure: a data synthesis. Mol Hum Reprod 2009;15:551-555.
15. Hempel N, How T, Cooper SJ, Green TR, Dong M, Copland JA,Wood CG, Blobe GC. Expression of the type III TGF-beta receptor is negatively regulated by TGF-beta. Carcinogenesis 2008;29:905-912. (Pubitemid 351993040)
16. Gatza CE, Oh SY, Blobe GC. Roles for the type III TGF-beta receptor in human cancer. Cell Signal 2010;22:1163-1174.
17. Shelling AN, Burton KA, Chand AL, van Ee CC, France JT, Farquhar CM, Milsom SR, et al. Inhibin: a candidate gene for premature ovarian failure. Hum Reprod 2000;15:2644-2649. (Pubitemid 32000524)
18. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005;15:97-98. (Pubitemid 41653949)
19. Welt CK, Taylor AE, Fox J, Messerlian GM, Adams JM, Schneyer AL. Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis. J Clin Endocrinol Metab 2005;90:5582-5587. (Pubitemid 41415462)
20. Stenvers KL, Tursky ML, Harder KW, Kountouri N, Amatayakul-Chantler S, Grail D, Small C, et al. Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos. Mol Cell Biol 2003;23:4371-4385. (Pubitemid 36666437)
21. Morén A, Ichijo H, Miyazono K. Molecular cloning and characterization of the human and porcine transforming growth factor-beta type III receptors. Biochem Biophys Res Commun 1992;189:356-362. (Pubitemid 23030049)